US lawmakers launch investigation into FDA approval and price of new Alzheimer's drug Advocates Chandigarh

Two House committees have launched an investigation into the approval and pricing of the Alzheimer's disease drug aducanumab, made by the company Biogen and sold under the brand name Aduhelm.

from AcquitLaw - Advocates Chandigarh | Lawyers in Chandigarh High Court Lawyers in Chandigarh